Minerva Neurosciences Inc (NERV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $114.62M
Last updated: Nov 17, 2026 at 4:10 PM ET
Minerva Neurosciences Inc (NERV) Statistics
Minerva Neurosciences (NERV) has a market cap of $114.62M and an enterprise value of $94.40M. Its share count is up 551.25% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 17.64% below the market cap, as cash exceeds debt.
| Market Cap | $114.62M |
|---|---|
| Enterprise Value | $94.40M |
| Latest price (Nov 17, 2026) | $2.16 |
Key Dates
The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 47.45% over 52 weeks and trades 26.03% below its 50-day average.
| Beta (1Y) | 1.70 |
|---|---|
| 52-Week Change | -47.45% |
| 1-Month Change | -6.90% |
| 3-Month Change | -54.91% |
| 6-Month Change | -50.46% |
| 5-Year Change | -79.29% |
| 10-Year Change | -97.40% |
| Total Return (1Y) | -47.45% |
| Total Return (3Y CAGR) | -25.48% |
| Total Return (5Y CAGR) | -25.56% |
| Return vs SPY (1Y) | -61.33% |
| Max Drawdown (1Y) | -73.23% |
| Max Drawdown (3Y) | -89.25% |
| Sharpe Ratio (1Y) | -0.77 |
| Correlation with SPY (1Y) | 0.26 |
| 50-Day Average | $2.92 |
| 200-Day Average | $4.79 |
| 52-Week Range | $1.96 to $8.80 |
| RSI (14 Days) | 36.8 |
| Average Volume (20 Days) | 192.12K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 33.02x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 33.02x |
|---|---|
| Quick Ratio | 33.02x |
| Debt / Equity | 0.00x |
| Interest Coverage | 1.04x |
Returns and Efficiency
| Return on Assets (ROA) | -295.96% |
|---|---|
| Return on Capital Employed (ROCE) | -14.55% |
| ROA (5Y Average) | -94.27% |
| ROIC (5Y Average) | 165.19% |
Scores
NERV has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$1.36K |
| Operating Income | -$41.73M |
| Pretax Income | -$290.81M |
| Net Income | -$290.86M |
| EBITDA | -$14.87M |
| EBIT | -$13.93M |
| Reported EPS (TTM) | -$27.74 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $20.22M |
|---|---|
| Total Debt | $0 |
| Net Cash | $20.22M |
| Net Cash Per Share | $0.41 |
| Working Capital | $80.88M |
| Shareholder Equity | -$97.52M |
| Tangible Book Value | -$112.39M |
| Total Assets | $98.28M |
| Total Liabilities | $184.06M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$31.40M |
|---|---|
| FCF Per Share | -$0.66 |
| Depreciation and Amortization | $935.93K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
NERV does not pay a dividend.
| Buyback Yield | 5.21% |
|---|---|
| Shareholder Yield | 5.21% |
Stock Splits
The last split was a 1-for-8 reverse split on Jun 21, 2022.
| Last Split Date | Jun 21, 2022 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:8 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About NERV
What is NERV's market cap?
Minerva Neurosciences has a market cap of $114.62M. Its enterprise value, which adds debt and subtracts cash, is $94.40M.
How many shares of NERV are outstanding?
Minerva Neurosciences has 49.29M shares outstanding. The count is up 551.25% from a year earlier.
Does NERV pay a dividend?
No. Minerva Neurosciences does not pay a dividend.
How much debt does NERV have?
Minerva Neurosciences has $0 of total debt and $20.22M of cash and equivalents, a net cash position of $20.22M.
NERV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors